Abstract:Camptothecin (CPT) is a potent anti-cancer agent targeting topoisomerase I (TOP1). However, CPT has poor pharmacokinetic properties, causes toxicities, and leads to drug resistance, which limit its clinical use. In this paper, to review the current state of CPT research. We first briefly explain CPT's TOP1 inhibition mechanism and the key hurdles in CPT drug development. Then we examine strategies to overcome CPT's limitations through structural modifications and advanced delivery systems....
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to improve the efficacy and safety of camptothecin (CPT) as an anticancer drug. Specifically, the paper focuses on the following aspects:
1. **Improving pharmacokinetic properties**:
- CPT has poor water solubility and bioavailability, which limit its clinical applications. The paper explores methods to improve these properties through structural modification and advanced delivery systems.
2. **Reducing toxic side effects**:
- CPT can cause severe toxic side effects at high doses, such as bone marrow suppression and gastrointestinal reactions. The paper discusses how to reduce these side effects by optimizing the structure and delivery system.
3. **Overcoming drug resistance**:
- Long - term use of CPT can lead to drug resistance in cancer cells, which is a major obstacle in the clinical application of CPT. The paper analyzes in detail the molecular mechanisms of drug resistance and proposes strategies to overcome these mechanisms.
4. **Enhancing anticancer activity**:
- Although CPT has significant cytotoxicity against multiple cancers, there is still room for improvement in its activity. Through structure - activity relationship (SAR) analysis, the paper explores how to improve the anticancer activity of CPT through structural modification.
### Main content of the paper
1. **Mechanism of action of CPT**:
- The paper first briefly introduces the mechanism by which CPT exerts its anticancer effect by inhibiting topoisomerase I (TOP1). CPT can stabilize the TOP1 - DNA complex and prevent DNA repair, thus leading to cell death.
2. **Structure - activity relationship (SAR) of CPT**:
- By studying structural modifications at different positions, the paper reveals which modifications can enhance the activity of CPT and which may lead to a decrease in activity. For example, modification at the C - 7 position can improve solubility by increasing hydrophilicity, while modification at the C - 10 position can increase TOP1 inhibitory activity.
3. **Mechanisms of CPT resistance**:
- The paper discusses in detail various mechanisms of CPT resistance, including drug efflux, changes in TOP1 structure or expression, changes in the cellular response to the formation of the CPT - DNA ternary complex, miRNA regulation, and the role of cancer stem cells.
4. **Strategies to overcome CPT resistance**:
- The paper proposes several strategies to overcome CPT resistance, including combination therapy and the development of new CPT derivatives. Combination therapy can restore drug sensitivity by targeting specific resistance mechanisms, while new derivatives can fundamentally overcome resistance.
5. **Structural modification and synthesis methods of CPT**:
- The paper reviews the semi - synthesis and total synthesis methods of CPT derivatives and discusses the advantages and disadvantages of various synthesis routes. In particular, the paper emphasizes the importance of the modular synthesis strategy, which can rapidly and efficiently synthesize multiple bioactive analogs.
6. **Delivery system of CPT**:
- The paper explores advanced delivery systems, such as antibody - drug conjugates (ADCs), nanotechnology, and other innovative formulations, which can improve the targeting, controlled release, and effectiveness of combination therapy of CPT.
### Conclusion
Through a comprehensive analysis of the research progress of CPT, the paper aims to provide guidance for future research to develop more effective CPT derivatives and delivery systems, so as to fully realize the anticancer potential of CPT.